Literature DB >> 26481951

Exploring miRNA based approaches in cancer diagnostics and therapeutics.

Shivangi Mishra1, Tanuja Yadav1, Vibha Rani2.   

Abstract

MicroRNAs (miRNAs), a highly conserved class of tissue specific, small non-protein coding RNAs maintain cell homeostasis by negative gene regulation. Proper controlling of miRNA expression is required for a balanced physiological environment, as these small molecules influence almost every genetic pathway from cell cycle checkpoint, cell proliferation to apoptosis, with a wide range of target genes. Deregulation in miRNAs expression correlates with various cancers by acting as tumor suppressors and oncogenes. Although promising therapies exist to control tumor development and progression, there is a lack of efficient diagnostic and therapeutic approaches for delineating various types of cancer. The molecularly different tumors can be differentiated by specific miRNA profiling as their phenotypic signatures, which can hence be exploited to surmount the diagnostic and therapeutic challenges. Present review discusses the involvement of miRNAs in oncogenesis with the analysis of patented research available on miRNAs.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; MicroRNAs; Oncogenes; Patents; Therapeutics; Tumor suppressors

Mesh:

Substances:

Year:  2015        PMID: 26481951     DOI: 10.1016/j.critrevonc.2015.10.003

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  139 in total

1.  The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells.

Authors:  Mengjia He; Qianni Jin; Cong Chen; Yifeng Liu; Xiangsen Ye; Yulin Jiang; Feihu Ji; Husun Qian; Delu Gan; Shujun Yue; Wei Zhu; Tingmei Chen
Journal:  Oncogene       Date:  2019-04-09       Impact factor: 9.867

Review 2.  MicroRNAs and Periodontal Homeostasis.

Authors:  X Luan; X Zhou; J Trombetta-eSilva; M Francis; A K Gaharwar; P Atsawasuwan; T G H Diekwisch
Journal:  J Dent Res       Date:  2017-01-09       Impact factor: 6.116

3.  [Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells].

Authors:  Kun Cao; Liangquan Sun; Yewei Zhang; Tengfei Wang; Haiyang Li; Shi Zuo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-09-30

4.  Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.

Authors:  Radhika Raheja; Keren Regev; Brian C Healy; Maria Antonietta Mazzola; Vanessa Beynon; Felipe Von Glehn; Anu Paul; Camilo Diaz-Cruz; Taha Gholipour; Bonnie I Glanz; Pia Kivisakk; Tanuja Chitnis; Howard L Weiner; James D Berry; Roopali Gandhi
Journal:  Muscle Nerve       Date:  2018-03-25       Impact factor: 3.217

5.  MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.

Authors:  Samantha M Ruff; Reed I Ayabe; Parisa Malekzadeh; Meghan L Good; Michael M Wach; Melissa K Gonzales; Amit Tirosh; Naris Nilubol; Karel Pacak; Electron Kebebew; Dhaval Patel
Journal:  J Surg Res       Date:  2019-05-27       Impact factor: 2.192

6.  Functional annotation of differentially expressed fetal cardiac microRNA targets: implication for microRNA-based cardiovascular therapeutics.

Authors:  Sharad Saxena; Anubhuti Gupta; Vaibhav Shukla; Vibha Rani
Journal:  3 Biotech       Date:  2018-11-21       Impact factor: 2.406

7.  Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer.

Authors:  Ming Bai; Peiyun Wang; Jiayu Yang; Mengsi Zuo; Yi Ba
Journal:  J Physiol Biochem       Date:  2020-07-31       Impact factor: 4.158

Review 8.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

9.  Downregulation of miR-19a inhibits the proliferation and promotes the apoptosis of osteosarcoma cells by regulating the JAK2/STAT3 pathway.

Authors:  Jiangqiang Chen; Zuhui Chen
Journal:  Oncol Lett       Date:  2020-08-28       Impact factor: 2.967

10.  MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer.

Authors:  Min Zheng; Zhihao Wu; Anqi Wu; Zhenyu Huang; Na He; Xiaohong Xie
Journal:  Tumour Biol       Date:  2016-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.